GB9722558D0 - Antigenically active proteins/polypeptides and coronavirus vaccines containing the same - Google Patents

Antigenically active proteins/polypeptides and coronavirus vaccines containing the same

Info

Publication number: GB9722558D0
Authority: GB; United Kingdom
Prior art keywords: polypeptides; same; active proteins; vaccines containing; antigenically active
Prior art date: 1993-09-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

GBGB9722558.5A

Other versions

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Dimminaco AG

Original Assignee

Dimminaco AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-16

Filing date

1993-09-16

Publication date

1997-12-24

1993-09-16 Application filed by Dimminaco AG filed Critical Dimminaco AG

1993-09-16 Priority to GB9722558A priority Critical patent/GB2316681B/en

1997-12-24 Publication of GB9722558D0 publication Critical patent/GB9722558D0/en

1998-03-04 Publication of GB2316681A publication Critical patent/GB2316681A/en

1998-04-15 Application granted granted Critical

1998-04-15 Publication of GB2316681B publication Critical patent/GB2316681B/en

2013-09-16 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/165—Coronaviridae, e.g. avian infectious bronchitis virus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Communicable Diseases (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Physics & Mathematics (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Plant Pathology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

GB9722558A 1993-09-16 1993-09-16 Antigenically active proteins/polypeptides and coronavirus vaccines containing the same Expired - Fee Related GB2316681B (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
GB9722558A GB2316681B (en)	1993-09-16	1993-09-16	Antigenically active proteins/polypeptides and coronavirus vaccines containing the same

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9722558A GB2316681B (en)	1993-09-16	1993-09-16	Antigenically active proteins/polypeptides and coronavirus vaccines containing the same
GB9319212A GB2282601B (en)	1993-09-16	1993-09-16	Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same

Publications (3)

Publication Number	Publication Date
GB9722558D0 true GB9722558D0 (en)	1997-12-24
GB2316681A GB2316681A (en)	1998-03-04
GB2316681B GB2316681B (en)	1998-04-15

Family

ID=10742112

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
GB9319212A Expired - Fee Related GB2282601B (en)	1993-09-16	1993-09-16	Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
GB9722558A Expired - Fee Related GB2316681B (en)	1993-09-16	1993-09-16	Antigenically active proteins/polypeptides and coronavirus vaccines containing the same

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
GB9319212A Expired - Fee Related GB2282601B (en)	1993-09-16	1993-09-16	Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same

Country Status (10)

Country	Link
EP (1)	EP0720654A1 (en)
JP (1)	JPH09509562A (en)
KR (1)	KR960705047A (en)
AU (1)	AU7615894A (en)
BR (1)	BR9407507A (en)
CA (1)	CA2171869A1 (en)
GB (2)	GB2282601B (en)
NO (1)	NO961086L (en)
WO (1)	WO1995007987A2 (en)
ZA (1)	ZA946887B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2724385B1 (en) *	1994-08-29	1996-12-13	Rhone Merieux	FELINE INFECTIOUS PERITONITIS VACCINE.
FR2741806B1 (en) *	1995-11-30	1998-02-20	Rhone Merieux	RECOMBINANT LIVING VACCINE BASED ON TYPE 1 FELINE HERPESVIRUS, PARTICULARLY AGAINST FELIN INFECTIOUS PERITONITIS
WO1998001570A2 (en) *	1996-07-05	1998-01-15	Vanderbilt University	Mutated antibody-dependent infection enhancing domains of hiv
FR2751223B1 (en) *	1996-07-19	1998-12-04	Rhone Merieux	FELIN POLYNUCLEOTIDE VACCINE FORMULA
CN1223605C (en) *	2003-05-16	2005-10-19	中国科学院微生物研究所	Polypeptide medicine for inhibiting SARS coronavirus, and derivatives and use thereof
CN113321714B (en) *	2020-02-28	2022-12-09	深圳市亚辉龙生物科技股份有限公司	Recombinant N protein of SARS-CoV-2 and its preparation and purification method
US20230331782A1 (en) *	2020-09-08	2023-10-19	The Trustees Of The University Of Pennsylvania	Compositions and Methods for Reducing Risk of Vaccine-Enhanced Disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU576907B2 (en) *	1984-11-01	1988-09-08	American Home Products Corporation	Oral vaccines comprising live recombinant adenoviruses
EP0264979A1 (en) *	1986-09-05	1988-04-27	Duphar International Research B.V	New antigenically active proteins and peptides, and feline infectious peritonitis virus (FIPV) vaccines
CA2005291C (en) *	1988-12-30	1999-01-26	Beverly Dale	Feline infectious peritonitis virus diagnostic tools
CA2020740A1 (en) *	1989-07-12	1991-01-13	Harry Vennema	Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines
NZ240558A (en) *	1990-11-14	1994-11-25	Smithkline Beecham Corp	Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
WO1993015762A1 (en) *	1992-02-18	1993-08-19	Parhelion Corporation	Feline infectious peritonitis vaccine and method of preparation
CA2135200C (en) *	1992-05-08	2001-03-27	Timothy J. Miller	Canine coronavirus s gene and uses therefor
AU678971B2 (en) *	1992-05-08	1997-06-19	Pfizer Inc.	Compositions and methods for vaccination against coronaviruses

1993
- 1993-09-16 GB GB9319212A patent/GB2282601B/en not_active Expired - Fee Related
- 1993-09-16 GB GB9722558A patent/GB2316681B/en not_active Expired - Fee Related
1994
- 1994-09-07 WO PCT/EP1994/002990 patent/WO1995007987A2/en not_active Application Discontinuation
- 1994-09-07 EP EP94926246A patent/EP0720654A1/en not_active Withdrawn
- 1994-09-07 AU AU76158/94A patent/AU7615894A/en not_active Abandoned
- 1994-09-07 ZA ZA946887A patent/ZA946887B/en unknown
- 1994-09-07 BR BR9407507A patent/BR9407507A/en not_active Application Discontinuation
- 1994-09-07 JP JP7508961A patent/JPH09509562A/en active Pending
- 1994-09-07 CA CA002171869A patent/CA2171869A1/en not_active Abandoned
- 1994-09-07 KR KR1019960701359A patent/KR960705047A/en not_active Application Discontinuation
1996
- 1996-03-15 NO NO961086A patent/NO961086L/en unknown

Also Published As

Publication number	Publication date
GB2316681A (en)	1998-03-04
WO1995007987A3 (en)	1995-06-22
GB2316681B (en)	1998-04-15
GB2282601A (en)	1995-04-12
ZA946887B (en)	1995-06-27
CA2171869A1 (en)	1995-03-23
GB9319212D0 (en)	1993-11-03
KR960705047A (en)	1996-10-09
NO961086L (en)	1996-05-09
GB2282601B (en)	1998-04-15
NO961086D0 (en)	1996-03-15
EP0720654A1 (en)	1996-07-10
AU7615894A (en)	1995-04-03
BR9407507A (en)	1997-01-07
WO1995007987A2 (en)	1995-03-23
JPH09509562A (en)	1997-09-30

Publication	Publication Date	Title
EP0950665A4 (en)	2004-05-06	Modified physiologically active proteins and medicinal compositions containing the same
ATE217787T1 (en)	2002-06-15	AEROSOL FORMULATIONS WITH PEPTIDES AND PROTEINS
HUP0103793A3 (en)	2003-09-29	N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them
EP0960885A4 (en)	2002-08-28	Depsipeptides and drugs containing the same as the active ingredient
GR3031296T3 (en)	1999-12-31	Cyclic peptides and use thereof
AU633294B2 (en)	1993-01-28	Motilin-like polypeptide and use thereof
GB9504040D0 (en)	1995-04-26	Arylsulfonamide derivative and pharmaceutical composition containing the same
GB9516293D0 (en)	1995-10-11	Novel peptides and their use as vaccines
ZA9410318B (en)	1995-08-01	Phenylmethyl hexanamides and the use thereof
ZA9410217B (en)	1995-08-25	Recombinant human thymopoietin proteins and uses therefor.
IL130348A0 (en)	2000-06-01	Imidazopyridazines and medicaments containing the same
GB2316681B (en)	1998-04-15	Antigenically active proteins/polypeptides and coronavirus vaccines containing the same
EP0970965A4 (en)	2002-07-17	Cyclic peptides and medicinal use thereof
IL110954A0 (en)	1994-11-28	Pharmaceutical compositions comprising a retinoblastoma polypeptide or protein, and methods for the preparation and use thereof
GB9317752D0 (en)	1993-10-13	New pharmaceutical use
HUP9901792A3 (en)	2000-04-28	An aqueous formulation comprising bambuterol and the use thereof
GB9302553D0 (en)	1993-03-24	Pharmaceutical preparations and their manufacture and use
ZA948685B (en)	1995-07-04	Vaccines
ZA948729B (en)	1995-07-10	Vaccines
ZA902869B (en)	1991-02-27	Novel peptides,and antidementia agents containing the same
HRP950267A2 (en)	1997-08-31	Heterocyclic compounds, pharmaceutical preparations containing them and the preparation thereof
ZA944483B (en)	1995-12-22	Peptides for use in medicine
IE891651L (en)	1989-11-27	Amphiphilic peptides and use thereof
SG69983A1 (en)	2000-01-25	Novel peptides the preparation and use thereof
CA73238S (en)	1993-09-23	Combined inhaler and cap

Legal Events

Date	Code	Title	Description
1999-05-05	PCNP	Patent ceased through non-payment of renewal fee	Effective date: 19980916